Reviews Open Access
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 15, 2000; 6(5): 633-635
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.633
Treatment revisited and factors affecting prognosis of severe acute pancreatitis
Xie Ning Wu, Department of Gastroenterology, Shanghai First Municipal People’s Hospital, Shanghai 200080, China
Xie Ning Wu, Professor of Medicine, BS, MD. Editor of seven books and fourteen invited reviews on books of hepatology and gastroenterology, having 186 papers published in Chinese and 16 papers in English both domestically and abroad.
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Xie Ning Wu, Department of Gastroenterology, Shanghai Municipal First People’s Hospital, No. 85 Wujin Road, Shanghai 200080, China
Telephone: 0086-21-62473001(H), 0086-21-63240090(O)
Received: February 24, 2000
Revised: March 5, 2000
Accepted: March 12, 2000
Published online: October 15, 2000

Abstract
Key Words: pancreatitis/therapy; prognostic factor analysis; inflammatory cytokines; necrosis; computed tomography; necrosectomy



INTRODUCTION

As stated in the author’s previous articles[1-5], severe acute pancreatitis is a multifacetted disease with rapid and sometimes fulminating onset and may result in many serious complications or even death if treatment is improper or delayed. Therapeutic measures must be directed against these multifa cets simultaneously with a view to achieve the optimum results. The following regime has been practised many years since 1990 and verified repeatedly as proper and adequate.

THERAPEUTIC REGIME OF SEVERE ACUTE PANCREATITIS

Early diagnosis is based on history, symptoms and signs, elevation of serum and/or urinary amylase and computed tomography (CT) of pancreas. Once the diagnosis is verified, treatment is immediately instituted, the treatment regime is listed in Table 1.

Table 1 Treatment regime of severe acute pancreatitis.
CT gradingTreatment
Grade A-COctreotide 0.1 mg q8h (H) × 5-7 d
Bulpleurum Peony Cheng Qi decoction bid × 5-7 d
Grade D-EOctreotide 0.1 mg/25% glucose IV
0.5 mg/5% glucose in saline 1000 mL/24 h
thereafter 0.6 mg/5% glucose in saline 1000 mL/24 h × 5-7 d or more
or Stilamin 6 mg/5% glucose in saline 1000 mL/24 h × 5-7 d
Bulpleurum Peony Cheng Qi decoction 150 mL bid × 5-7 d
Plasma 400 mL-600 mL stat, 200 mL on 2nd and 3rd day each
Human serum albumin 10-20 g/d
Low molecular weight dextran (-40) + Dan Shen liquid 16-20 mL/glucose water
250 mL × 1-2 d, thereafter Dan Shen liquid in glucose in saline × 3-5 d
Ciprofloxacin 0.2 g bid + Metronidazole 100 mL bid × 4 weeks
or Imipenum 0.5 g q8h × 4 weeks
Compound aminoacids 500-750 mL qd, Intralipid 10% 500 mL qd
Fasting for food but not the herbal medicine
Omeprazole 40 mg IV gtt. qd × 7 d,
and then 20 mg per oral qd × 2-3 weeks
No atropine or gastric decompression
Calcium, potassium salts supplement with occasional magnesium salt

Octreotide (Sandostatin) and the herbal medicine, Bulpleurum Peony Cheng Qi decoction have synergistic effects, their effects are depicted in Table 2.

Table 2 Effects of Octreotide and the herbal medicinals.
DrugEffects
OctreotideInhibits release of CCK and pancreatic enzymes
(Sandostatin)[5]Stimulates and activates macrophages, lowering endotoxin level[6]
Blocks release of inflammatory cytokines[7]
Redistributes intrapancreatic blood flow
Attenuates the interaction of neutrophils and endothelial cells[8]
Inhibits eicosanoid and products as PGI2, leucotrienes
Relaxes Oddi’s sphincter
BulpleurumInhibits secretion and activities of pancreatic enzymes
PeonyStabilizes lysosomal membrane
Cheng QiInhibits inflammatory cytokines, IL-1, IL-6, IL-8, and TNF-α;
decoction[5]Inhibits vascular permeability[9]
Increase peristalsis with purgating effect, expelling bacterial flora
and endotoxin
Protects gut mucosal barrier, preventing bacteria dislocation[10,11]
Relaxes Oddi’s sphincter
Reduces urea synthesis, promotes urinary excretion of urea and
creatinine
Has broad antibiotic spectrum, including B. Fragilis
Stimulates secretion of endogenous glucocorticoids which can inhibit
cytokines and inflammatory mediators
Decreases blood lipids, inhibits lipid peroxidation
Inhibits TXA2 synthase, promotes PGE1 PGE2 levels, inhibits
transformation of fibrinogen to fibrin and prevents endotoxin
induced DIC
Dan ShenInhibits platelet aggregation, decreases blood viscosity, improves
(Salviablood rheology and microcirculation
Miltiorrhiza)Inhibits lysosomal enzymes and chemotactic neutrophils
Blockage of calciumion influx
Has antioxidation effect, ameliorates inflammation and tissue damage

In Balthazar’s CT grading of D and E, there are always profuse exudation peripancreatically and sometimes massive into the peritoneal cavity and retroperitoneal space, plasma is always needed to improve the hypovolemia, and human albumin for hypoalbuminemia even when hypotension or shock is absent. When the hemodynamics become stabilized, intravenous hyperalimentation should be given. Octreotide and the herbal mixture are administered simultaneously at the start, the abdominal pain and abdominal distention usually subside within 1-3 d. Usually the patients run a smooth course without much fluctuation in one to one and a half months. Another important point is that food must be restricted until one month later after abatement of all symptoms and signs.

By the above regime, 20 cases of grade D and 10 cases of grade E recovered uneve ntfully with no mortality, almost no morbidity and no serious complications as ARDS, gastrointestinal failure and disseminated intravascular coagulopathy (DIC).

FACTORS AFFECTING THE PROGNOSIS OF SEVERE ACUTE PANCREATITIS
Extent of necrosis and time of treatment after onset of the disease

The extent of necrosis can be categorized into ≤ 30%, 30%-50% and > 50% of the surface area of pancreas shown in CT, which is relevant to the time of treatment given. The necrotic process is dynamic in nature, if diagnosed within 24 h-48 h after disease onset, the extent of necrosis is usually ≤ 30%, if diagnosed after 72 h, it may progress to 30%-50% or even > 50% even if the treatment is proper and adequate, the pathophysiologic changes can be more complicated, the rate of infection of intestinal origin is also higher with usher in of systemic inflammatory response syndrome (SIRS), then treatment can be more difficult with worser prognosis. In America, the mortality rate of this particular disease was around 17%-20%, because the CT report usually took three days and this delay would enable progression of necrosis to the extent of 30%-50% or even > 50% with higher mortality rate.

Proper, improper and/or inadequate treatment at the beginning

The key element in determining the prognosis of the disease is the treatment given at the start, with idiopathic severe acute pancreatitis, treatment is mainly medical, if with presence of common duct stone obstruction, emergency endoscopic or surgical removal of stone is necessary.

The comprehensive medical treatment is listed in Table 1, continuous infusion of Octreotide gives better results than 0.1 mg q8h given hypodermically, in the latter, sepsis occurred in 26%, and ARDS in 37%[12]. Adequate plasma, albumin, low molecular weight dextran and Dan Shen restore the blood volume and improve the microcirculation of pancreas and other vital organs. Concomitantly, Blupleurum-Peony-Cheng Qi decoction is given which has seven constituents, including: Bulpleurum, White peony, Scutellaria, Unripe bitter orange, Magnola bark, Refined mirabilite and Rhubarb, each 10 g. It is prepared by adding 100-150 water to the first five constituents, and heated for 20 min, at the 18th min, add Rhubarb (wrapped by cloth), heat only for two min, then decant the liquid and dissolve the refined Mirabilite (Na2SO4) crystals in it and drink. The mixture is taken twice a day by repetition of the same procedure. This herbal medicine should be taken orally for 5-7 d. No atropine, nor gastric decompression is allowed.

Combination of these measures can ameliorate the pancreatic autodigestion caused by release of pancreatic and lysosomal enzymes and ischemia-reperfusional damage significantly, it can also halt the exudation, and avoid the complications of the kidney, lung and GI tract. This herbal mixture can inhibit the excessive stimulation of macrophages; reduce the release of inflammatory cytokines, decrease the neutrophilic infiltration and its interaction with vascular endothelial cells, maintaining the gut barrier function, preventing the second attack which leads to SIRS.

Among the destructive enzymes, phospholipase A2 (PLA2) and lipase are most crucial, PLA2 can destroy the phospholipid structure of cell membranes of GI tract, lung and brain. The lipase can degradate the fat which produce toxic free fatty acids injuring the capillaries and increase lipoperoxidation[13]. The cytokines damaging vital organs include IL-1, IL-6, IL-8, TNF-α, INF-γ and PAF. Among these, PAF and TNF-α increase vascular permeability which not only play important pathophysiological role in the pancreas itself but also cause complications in the lungs, brain and GI tract. By given Octreotide (Sandostatin) with concomitant herbal mixture, the damage caused by the above factors can be much reduced. Sandostatin and the herbal mixture have synergistic effects on inhibition of activated pancreatic enzymic activities and their secretion, also have complementary effect on interaction of the neutrophils and endothelial cells, and inhibition of neutrophilic infiltration in the pancreas and in the lung, thus is crucial in the treatment of severe acute pancreatitis.

When given Sandostatin or oral herb mixture singly and without given plasma, human serum albumin, but infuse large volume of balance solution or glucose in saline, these not only cannot act on simultaneously, but also may lead to cardiac and pulmonary failure, this may be one of the causes of high mortality rate and high complication rate as reported in the medical literature both domestically and abroad.

Whether preventive treatment has been instituted?

During admission, Omeprazole (Losec) should be given intravenously to prevent acute gastric mucosal bleeding; ciprofloxacin and metronidazole or imipenum to prevent infection, besides, the Rhuberb and Scutallaria have also antibiotic activities. Rhuberb also abolishes paralytic ileus, expel the bacteria flora together with endotoxin via the anus. The antibiotics shown above have penetrating abilities into the necrotic tissue or necrotic fluid, if other antibiotics are used instead or by rotation would not only be ineffective, but also lead to superinfection in these immunocompromized patients. Once the hemodynamic changes return to normal after correction of hypovolemia, total parenteral nutrition should be instituted to maintain positive nitrogen balance, in case with SIRS, more calories should be given regularly up to 2500-3000 Kal/d or more. Regular insulin should also be given to maintain normal blood sugar level. Supplements of calcium, potassium and magnesium salts are also required for hypocalcemia and hypopotassemia. Local fluid collection is best to be left alone without aspiration, this will be absorbed during convalescence.

During the early period, one should pay attention to avoid cardiac or renal failure, also the ARDS, in the middle period, one should notice and prevent the occurrence of pancreatic encephalopathy; late in the course, one should be aware of infection and residual infection. Food fasting but allow oral herb mixture only would take one month, early feeding can give rise to recrudescence. If one is not aware of the complicated and multifaceted nature of the disease and has not paid great attention to the preventive measures, SIRS, multiple organ dysfunction syndrome (MODS) and eventually multiple organ failure (MOF) would be unavoidable. For SIRS, short-term hemofiltration had been adopted by the surgical pancreatology group of Shanghai Ruijin Hospital to downregulate the level of inflammatory cytokines and upregulate the antiinflammatory cytokines (IL-10) level which could shorten the course and hasten recovery[14].

Can the precipitating factors be removed or not?

The precipitating factors as microlithiasis or cholesterol crystals from the gallbladder, the high fat, high protein diet and alcohol drinking were removed after treatment and fasting, the patient usually recovered clinically in 1-1.5 months, and the pancreas showed normal texture by CT by another 1-1.5 months. But when hyperlipidemia is the inducing factor, the lipoperoxidation and pancreatic ischemia are especially severe, the reason is stated above, the course is usually fulminating, because short-acting hypolipidemic agent for intravenous use is currently unavailable, especially in those with coexistent fatty liver, the oxidation of fatty acid by the mitochondria of the liver cells cannot be augmented, the severe ischemia and lipoperoxidation would result in extensive pancreatic necrosis, and because of the persistence of free fatty acid as the stimulus, numerous complications may set in, making treatment even more difficult, fortunately this precipitating factor is rare here.

Functional status of vital organs

Aged patients usually have degeneration and deteriorating function of many vital organs, diseases as ischmic heart, hypertension, diabetes, chronic bronchitis with emphysema, chronic liver disease, impaired kidney function or even lacunar infarction of brain are common, any one or two coexisted can add further embarra ssment to the management, fortunately the severe acute pancreatitis among the aged is milder than that in the middle-aged and younger patients, they are mostly of grade C and B, whereas grade D is only occasional[15]. One must be very careful throughout the course of treatment, detailed history, physical examination, blood chemistry, blood gas analysis, electrocarcinogram should be performed on admission, fluid given must be concordant with the tolerability of patient’s heart and circulation, the rate of fluid infusion shoumd be slow to avoid the unnecessary occurrence of heart failure. In case when heart failure occurs, cedilanid and dobutamine should be given to increase myocardial contractility and phentolamine to diminish the pre-and afterload. At the same time, one should also pay attention to the renal function because cardiac and renal functions are interrelated, with both cardiac and renal incompetence, the condition is usually detrimental and may be fatal.

Whether necrosectomy is timely and thorough?

With stone obstructing the pancreatico-biliary common pathway, ERCP or endoscopic sphincterotomy should be tried first, or emergency surgery to relieve obstruction with common duct T-tube drainage, but leave the pancreatic necrosis aside, operation should be as simple as possible, afterwards, comprehensive medical therapy should be instituted immediately. With nonstone obstruction where necrosis is extensive and severe, patient should be placed in ICU, given energetic medical treatment and watched carefully by dynamic CT and other measures, in case of progression of the disease, necrosectomy should be performed with thorough removal of necrotic foci. Acute peritonitis occasionally requires laparotomy for drainage, followed by short-term peritoneal lavage when there is profuse exudation and fluid collection in the peritoneal cavity and retroperitoneal space. The peritoneal exudative fluid contains PLA2, protease, bradykinin, PAF, prostaglandins and complement component which should be evaculated. Necrosis with infection if can be controlled by antibiotics, operation may be spared, but if it is uncontrollable, surgery should be performed to remove the infected necrotic foci within the pancreas, the peritoneal cavity and retroperitoneal space thoroughly. These are the surgical viewpoints of the expertised surgeon Zhang ZT of Ruijin Hospital[16].

Footnotes

Edited by Ma JY

References
1.  Wu XN. Preventive treatment of severe acute pancreatitis and comp lications. Neike Jiweizhongzheng Zazhi. 1995;1:2-4.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Wu XN. How to lower the mortality and morbidity rate and assess the severity of severe acute pancreatitis. Weichang Bingxue. 1999;4:46-48.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Wu XN. Pathogenesis and treatment of severe acute pancreatitis. New theory and technology of gastroenterology. Shanghai: Shang-hai Science and Technology Educational Publisher 1999; 477-487.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Wu XN. Current concept of pathogenesis of severe acute pancreatitis. World J Gastroenterol. 2000;6:32-36.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Wu XN. The mechanism of actions of Octreotide, Bupleurum-Peony Cheng Qi decoction and Dan Shan in severe acute pancretitis. World J Gastroenterol. 1999;5:249-251.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Büchler MW, Binder M, Friess H. Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis. Gut. 1994;35:S15-S19.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Zhang QH, Cai D, Wu SC, Jiang YF, Hou LD, Zhang YL. Changes of inflammatory mediators in acute necrotizing pancreatitis rats and the effect of somatostatin. Zhonghua Yixue Zazhi. 1997;77:355-358.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Hoffmann TF, Uhl E, Messmer K. Protective effect of the somatostatin analogue octreotide in ischemia/reperfusion-induced acute pancreatitis in rats. Pancreas. 1996;12:286-293.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 26]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
9.  Chen DZ, Yan JD, Jing BW. Influence of Rhubaeb on rats intestinal mucosa and intestinal vascular permeability. Ibid. 1996;9:385-387.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Chen DZ, Yang XY, Jing BW. Study on protection effect of gastr ointestinal mu-cosal barrier by Rhubarb. Zhongguo Weizhongbing Jijiuyixue. 1994;6:329-331.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Chen DZ, Jing BW. Experimental study on effect of Rhubarb on infection of intestinal origin. Ibid. 1993;3:7.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Paran H, Neufeld D, Mayo A, Shwartz I, Singer P, Kaplan O, Skornik Y, Klausner J, Freund U. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis. J Am Coll Surg. 1995;181:121-124.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Morita Y, Yoshikawa T, Takeda S, Matsuyama K, Takahashi S, Yoshida N, Clemens MG, Kondo M. Involvement of lipid peroxidation in free fatty acid-induced isolated rat pancreatic acinar cell injury. Pancreas. 1998;17:383-389.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
14.  Mao EQ, Tang YQ, Han TZ, Jue HP, Yuan ZY, Yin HR, Zhang ST, Wang GY. Study on the mechanism of short term veno venous hemofilration in the t reatment of severe acute pancreatitis. W. aike Lilun Yu Shijian. 1998;3:231-235.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Wu XN. Treatment of severe acute pancreatitis and chronic pancreatitis in the elderly. J Practical Geriatrics. 1999;13:4-6.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Zhang ST. Suggestions for promoting the treatment level in the field of surgical pancreatology in China, Editorial. Waike Lilun Yu Shijian. 1998;3:73-74.  [PubMed]  [DOI]  [Cited in This Article: ]